Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.21.2
Segment Information (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Jun. 30, 2021
USD ($)
segment
Jun. 30, 2020
USD ($)
Segment Reporting [Abstract]            
Number of operating segments | segment         2  
Segment Reporting Information [Line Items]            
Total revenue $ 121,724   $ 86,977   $ 237,257 $ 193,007
Total cost of revenue 68,734   58,971   142,693 118,632
Total gross profit 52,990   28,006   94,564 74,375
General and administrative 54,638   34,613   95,114 70,957
Research and development 3,495   2,105   5,951 4,165
Sales and marketing 17,224   10,195   30,973 23,453
Total operating expenses 75,357   46,913   132,038 98,575
Loss from operations (22,367)   (18,907)   (37,474) (24,200)
Interest expense, net 902   1,548   2,079 2,367
Other income, net (171)   (7,405)   (341) (7,628)
Gain on investment in and loan receivable from non-consolidated affiliate, net (96,534)   0   (91,510) 0
Loss on extinguishment of debt 0   1,400   0 1,400
Loss on termination of cash flow hedge 0   3,506   0 3,506
Income (loss) before taxes 73,436   (17,956)   52,298 (23,845)
Income tax benefit (2,437)   (11,132)   (1,461) (10,043)
Net income (loss) 75,873 $ (22,114) (6,824) $ (6,978) 53,759 (13,802)
Clinical Services            
Segment Reporting Information [Line Items]            
Total revenue 101,405   73,884   197,892 166,866
Total cost of revenue 57,233   48,757   118,798 97,680
Total gross profit 44,172   25,127   79,094 69,186
Amortization of acquired intangible assets 700       700  
Clinical Services | COVID-19 PCR Testing            
Segment Reporting Information [Line Items]            
Write off of COVID-19 PCR testing inventory         5,300  
Pharma Services            
Segment Reporting Information [Line Items]            
Total revenue 20,319   13,093   39,365 26,141
Total cost of revenue 11,501   10,214   23,895 20,952
Total gross profit $ 8,818   $ 2,879   $ 15,470 $ 5,189